Track topics on Twitter Track topics that are important to you
Stifel has raised its price target for Cara Therapeutics (NASDAQ:CARA) to $25 from $20 after the company announced positive top-line Phase 2 proof-of-concept data for IV-CR845 in uremic pruritus, or c...
Cara Therpeutics' stock soared on 23 July after the company announced positive mid-stage results for its anti-itch medication.
Cara Therapeutics Inc. (NASDAQ:CARA) gained $3.15 (20%) to $18.99 on Thursday after IV CR845 met the primary endpoint of a Phase II trial to treat uremic pruritus. The long-acting peripheral kappa opi...
Cara Therapeutics Inc. (pain and dermatological conditions) netted $65.8mm in a follow-on public offering of 3.8mm shares for $18.60. The company will spend the money on clinical trials of the IV and ...
Cara Therapeutics Inc. (pain and dermatological conditions) netted $75.7mm in a follow-on public offering of 4.3mm shares (including the overallotment) for $18.60. The company will spend the money on ...
Biotechnology firm Cara Therapeutics has enrolled first patients in a Phase II trial of an oral tablet formulation of its peripherally selective kappa opioid agonist CR845 to treat osteoarthritis (OA)...
Pin-X Chewable Tablets PINWORMTREATMENT
Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is part...
Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...
Me es grato darles la bienvenida a la página web del INSTITUTO DE CIRUGIA MAXILOFACIAL E IMPLANTOLOGIA.El Instituto, fundado en Mayo del 2000, tiene como objetivo el tratamiento integral médico-quir...
We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.